DM Pharm Flashcards
Biguanides
MOA: inhibits hepatic glucose production (gluconeogenesis and glycogenolysis) and improves insulin sensitivity
Metformin (Glucophage)
Metformin/Glyburide (Glucovance)
Metformin/Glipizide (Metaglip)
Biguanides Contraindications
Alcoholics
Discontinue temporarily if receiving iodinated contrast
Renal dysfunction
Serum creatinine ≥1.5 mg/dL in males or ≥1.4 mg/dL in females)
BBW: Lactic Acidosis
Sulfonylureas
Glipizide(Glucotrol) (Glucotrol XL)
Glyburide(Diabeta) (Micronase) (Glynase)
Glimepiride (Amaryl)
Correct derangements of metabolism of
Carbohydrates, lipid and proteins
Sulfonylureas MOA
Bind to beta cell receptors and cause ATP-dependent potassium channels to close
The calcium channels then open = ↑ cytoplasmic calcium = ↑ insulin release from pancreas
Sulfonylureas: critical information to know
Does nothing to increase insulin sensitivity
1/3 of patients with T2DM fail to respond adequately
Major risk of hypoglycemia (Elderly, ETOH abuse, poor nutrition, renal insufficiency)
WEIGHT GAIN
Thiazolidinediones aka TZDs
Rosiglitazone (Avandia)
Pioglitazone (Actos)
MOA: Increase insulin sensitivity in skeletal muscle and fat thereby decreasing peripheral insulin resistance
TZDs Black box warning
Congestive heart failure
Rosiglitazone BBW: Myocardial infarction
Alpha-glucosidase inhibitors
Acarbose (Precose)
MOA: Slows the absorption of carbohydrates
Meglitinides
Nateglinide (Starlix)
Repaglinide (Prandin)
MOA: similar to sulfonylureas, increases insulin secretion from the pancreas
Uses of meglitinides
Alternative for patients who are candidates for Sulfonylurea’s but have a sulfa allergy
Dipeptidyl Peptidase-4 Inhibitors
Sitagliptin (Januvia)
Saxtagliptin (Onglyza)
MOA: inhibits the enzyme that breaks down endogenous GLP-1 thereby allowing increased amounts
Amylinomimetic
Pramlintide acetate (Symlin) Reduces postprandial glucose increases via the following mechanisms: 1) prolongation of gastric emptying time 2) reduction of postprandial glucagon secretion 3) reduction of caloric intake through centrally-mediated appetite suppression
Insulin
Aggressive treatment which requires close monitoring of blood sugar levels and frequent doses of insulin.
Close following of eating and exercise plans.
Intensive Insulin Therapy Goals
Blood sugar level before meals
90-130
Blood sugar level two hours after meals
Less than 180
Hemglobin A1C
less than 7%
Insulin categorized as
Basal- long acting
NPH, lente, glargine, detemir
Bolus-eating, short acting
Regular, lispro, aspart, glulisine